Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
J Mol Neurosci ; 46(1): 10-7, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21547533

ABSTRACT

Orexins A and B are newly discovered neuropeptides with pleiotropic activity. They signal through two G protein-coupled receptors: OX(1) and OX(2). In this study, we examined the expression of orexin receptors and effects of the receptors' activation on cyclic AMP formation in the primary neuronal cell cultures from rat cerebral cortex. Both types of orexin receptors were expressed in rat cortical neurons; the level of OX(2)R was markedly higher compared to OX(1)R. Orexin A (an agonist of OX(1)R and OX(2)R) and [Ala(11)-D-Leu(15)]orexin B (a selective agonist of OX(2)R) did not affect basal cyclic AMP formation in the primary neuronal cell cultures. Both peptides (0.001-1 µM) inhibited, in a concentration-dependent manner and IC(50) values in low nanomolar range, the increase in the nucleotide production evoked by forskolin (1 µM; a direct activator of adenylyl cyclase), pituitary adenylate cyclase-activating polypeptide (PACAP27; 0.1 µM), and vasoactive intestinal peptide (VIP; 3 µM). Effects of orexin A on forskolin-, PACAP27-, and VIP-stimulated cyclic AMP synthesis were blocked by TCS OX2 29 (a selective antagonist of OX(2)R), and unaffected by SB 408124 (a selective antagonist of OX(1)R). Pretreatment of neuronal cell cultures with pertussis toxin (PTX) abolished the inhibitory action of orexin A on forskolin- and PACAP-stimulated cyclic AMP accumulation. It is suggested that in cultured rat cortical neurons orexins, acting at OX(2) receptors coupled to PTX-sensitive G(i) protein, inhibit cyclic AMP synthesis.


Subject(s)
Cyclic AMP/antagonists & inhibitors , Cyclic AMP/biosynthesis , GTP-Binding Protein alpha Subunits, Gi-Go/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Neurons/metabolism , Neuropeptides/metabolism , Receptors, G-Protein-Coupled/physiology , Receptors, Neuropeptide/physiology , Animals , Intracellular Signaling Peptides and Proteins/physiology , Neurons/cytology , Neuropeptides/physiology , Orexin Receptors , Orexins , Primary Cell Culture , Rats , Rats, Wistar , Signal Transduction/drug effects , Signal Transduction/physiology
2.
Postepy Biochem ; 52(1): 35-41, 2006.
Article in Polish | MEDLINE | ID: mdl-16869299

ABSTRACT

14-3-3 proteins compose a large family of proteins that exist primarily as homo- and heterodimers within all eukaryotic cells. They are engaged in the regulation of numerous cellular processes, including melatonin biosynthesis. Melatonin, the hormone of darkness, is synthesized in a diurnal or circadian rhythm, with high levels at night. It has been demonstrated that cAMP levels and PKA activity in melatonin-synthesizing cells (pinealocytes and retinal photoreceptors) increase at night. PKA phosphorylates serotonin N-acetyltransferase (AANAT; the penultimate and key regulatory enzyme in melatonin biosynthesis pathway) at its N- (Thr31) and C-(Ser205)terminal region. Phosphorylated of AANAT bind to 14-3-3 proteins. The formation of pAANAT/14-3-3 complex stabilizes the enzyme and protects it against proteolytic destruction. Furthermore, this complex induces allosteric changes of the AANAT molecule resulting in an increase of the enzyme activity; this in turn enhances melatonin production by several fold. Exposure to light at night decreases intracellular cAMP level with concomitant dephosphorylation of pAANAT, its dissociation from 14-3-3 dimers, proteosomal proteolysis of free AANAT molecules, and finally turning off the melatonin production.


Subject(s)
14-3-3 Proteins/metabolism , Arylalkylamine N-Acetyltransferase/metabolism , Cyclic AMP/metabolism , Melatonin/biosynthesis , Animals , Arylalkylamine N-Acetyltransferase/drug effects , Circadian Rhythm/physiology , Darkness , Enzyme Inhibitors/pharmacology , Humans , Light , Models, Biological , Photoperiod , Protein Conformation
SELECTION OF CITATIONS
SEARCH DETAIL
...